Applied Therapeutics Inc (APLT)
4.53
+0.09
(+2.03%)
USD |
NASDAQ |
May 02, 16:00
4.53
0.00 (0.00%)
After-Hours: 20:00
Applied Therapeutics Cash from Operations (TTM): -55.17M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -55.17M |
September 30, 2023 | -54.06M |
June 30, 2023 | -58.72M |
March 31, 2023 | -60.67M |
December 31, 2022 | -78.09M |
September 30, 2022 | -89.14M |
June 30, 2022 | -85.42M |
March 31, 2022 | -92.92M |
December 31, 2021 | -90.73M |
September 30, 2021 | -86.54M |
June 30, 2021 | -91.56M |
Date | Value |
---|---|
March 31, 2021 | -81.57M |
December 31, 2020 | -78.21M |
September 30, 2020 | -67.87M |
June 30, 2020 | -55.01M |
March 31, 2020 | -48.16M |
December 31, 2019 | -36.31M |
September 30, 2019 | -29.77M |
June 30, 2019 | -23.95M |
March 31, 2019 | -17.05M |
December 31, 2018 | -11.18M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-92.92M
Minimum
Mar 2022
-23.95M
Maximum
Jun 2019
-66.52M
Average
-67.87M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Sarepta Therapeutics Inc | -500.99M |
Fate Therapeutics Inc | -132.26M |
Viking Therapeutics Inc | -54.87M |
Terns Pharmaceuticals Inc | -67.39M |
Edgewise Therapeutics Inc | -91.95M |